Funder: AstraZeneca United States
Due Dates: Rolling (applications reviewed and approved on a rolling basis)
Funding Amounts: Up to $150,000–$200,000 total program budget; multi-support acceptable.
Summary: Grant supports independent medical education programs delivering practical updates from the 2026 ESMO-GI congress on hepatocellular carcinoma to US clinicians.
Key Information: Program must be accredited, non-promotional, and fully compliant with ACCME and FDA guidance.